1,5-anhydro-1-(5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl)-1-thioglucitol

Preferred Label : 1,5-anhydro-1-(5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl)-1-thioglucitol;

MeSH note : an antidiabetic agent that inhibits sodium-dependent glucose cotransporter 2 (SGLT2); structure in first source;

CISMeF synonym : TS 071;

MeSH synonym : luseogliflozin;

MeSH hyponym : TS071 cpd; TS-071;

Is substance : O;

UNII : C596HWF74Z;

InChIKey : WHSOLWOTCHFFBK-ZQGJOIPISA-N;

Details

Origin ID

C549343;

UMLS CUI

C2933904;

ATC code(s)
- luseogliflozin [ATC Code]
Currated CISMeF NLP mapping
- Luseogliflozin [NCIt concept]
MeSH term(s) associated for indexing
- sorbitol [MeSH Descriptor]
Record concept(s)
- 1,5-anhydro-1-(5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl)-1-thioglucitol [MeSH concept]
- Lusefi [MeSH concept]
- TS 071 [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Luseogliflozin [NCIt concept]
- luseogliflozin [ATC Code]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients